Yashoda Hospitals, Hyderabad, is the first in India to introduce Bronchoscopic Thermal Vapour Ablation (BTVA), an endoscopic lung volume reduction (ELVR) treatment designed to reduce hyperinflation and improve respiratory mechanics in patients with severe emphysema.

BTVA is a simple, quick, and minimally invasive procedure that typically takes less than 15 minutes and can be performed under light sedation.

Bronchoscopic Thermal Vapour Ablation (BTVA) represents one of the advanced endoscopic lung volume reduction (ELVR) techniques aimed at reducing hyperinflation in patients with advanced emphysema, thereby improving respiratory mechanics. Through targeted segmental vapor ablation, an inflammatory response is induced, leading to tissue and volume reduction in the most diseased emphysematous segments. As a result, adjacent healthier lung segments function more effectively, reducing lung overinflation and making breathing easier for the patient. Post-treatment, patients experience significant symptom relief, improved lung function, and a better quality of life.

The procedure is typically performed under deep sedation or, preferably, general anesthesia. After positioning the BTVA catheter and occluding the target segment with the occlusion balloon, heated water vapor is delivered for a predetermined duration, based on the vapor dose.

Benefits of Bronchoscopic Thermal Vapour Ablation (BTVA):

• Reduces the risk of COPD symptoms and hospitalizations.
• Shows clinical improvement in pulmonary function tests (PFT) and exercise capacity.

Yashoda Hospitals is one of India’s largest quaternary centers for Pulmonology and Critical Care, with three decades of healthcare excellence. We specialize in treating a high volume of pulmonary critical care patients through minimally invasive procedures, ensuring the best outcomes for our patients.